Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia

BACKGROUND: Myocyte enhancer factor 2D (MEF2D) is involved in the progression of various malignant tumors. However, its impact on B-cell acute lymphoblastic leukemia (B-ALL) has not been elucidated. METHODS: In this study, the expression level of MEF2D in B-ALL patients was validated through the Gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ning, Feng, Jianhua, Liao, Peiyun, Hu, Yuxing, Li, Meifang, He, Yanjie, Li, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007885/
https://www.ncbi.nlm.nih.gov/pubmed/36915581
http://dx.doi.org/10.21037/tcr-22-1778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007885/
https://www.ncbi.nlm.nih.gov/pubmed/36915581
http://dx.doi.org/10.21037/tcr-22-1778

Ejemplares similares